Medication info

Olmesartan Medoxomil 40 mg Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201100868 · Approved 2011.02.22

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while monitoring the patient's condition closely. <Elderly patients> No dose adjustment is required when administering this drug to elderly patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
Child dose
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension refers to a condition where blood pressure remains persistently high, requiring treatment to reduce the risk of cardiovascular disease. This medication helps control blood pressure in patients with essential hypertension and prevents complications such as heart disease and stroke. By stabilizing blood pressure through treatment, it aids in improving overall health. This drug is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at about 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while monitoring the patient's condition closely. <Elderly patients> No dose adjustment is required when administering this drug to elderly patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.

Child dose

<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it must be stopped immediately if pregnancy is confirmed. This medicine should not be administered to individuals who are allergic to this drug or its components, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver impairment, patients with biliary obstruction, or patients with genetic issues such as lactose intolerance. Patients with decreased blood volume or salt, patients with impaired renal function, patients with renovascular hypertension, patients at risk for hyperkalemia, and patients with aortic or mitral valve stenosis must use this medication cautiously and should have their blood pressure, kidney function, and electrolyte levels regularly monitored during treatment. Dizziness may occur while taking this medication, so it is advisable to avoid hazardous machinery operations such as working at heights or driving. This medication is used for hypertension treatment and is generally safe for most patients; however, some may experience side effects such as dizziness, headache, abdominal pain, muscle pain, or rash. Rarely, serious adverse reactions may occur, such as angioedema, liver function abnormalities, hyperkalemia, or acute kidney failure, so if any unusual symptoms arise, immediate consultation with healthcare professionals is necessary. This medication may interact when used in combination with other potassium-sparing diuretics, antihypertensive agents, lithium, or nonsteroidal anti-inflammatory drugs, so it is crucial to inform your healthcare provider about any other medications being taken. In pregnant women, this drug should be avoided for the welfare of the fetus, and breastfeeding women should discontinue nursing or stop taking this medication due to potential adverse effects on infants. Safety in children has not been established, so this medication should not be administered to pediatric patients. Elderly patients may have increased drug concentration in the body, necessitating dosage adjustments and caution. In case of overdose, hypotension and palpitations may occur; if symptoms are severe, immediate contact with healthcare professionals for appropriate treatment is necessary. Long-term use of this medication has not shown any carcinogenic risk; however, if unusual symptoms develop during treatment, immediate consultation with a specialist is necessary.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • elevated creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 36 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • dyslipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • weakness
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • hypertension
  • epistaxis
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, at a safe room temperature between 1°C and 25°C. Therefore, it is essential to store it under proper temperature and environmental conditions to maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.